Implantica’s RefluxStop™ stimulates intensive dialogue at DDW, the world’s largest Digestive Disease conference, held in the U.S.

VADUZ, Liechtenstein, May 27, 2025 /PRNewswire/ — Implantica AG (publ.) reports successful pre-launch activities in the U.S., pending FDA approval, with European real-world clinical evidence generating much interest from U.S. surgeons. Several presentations on RefuxStop™ were held at…